Medical/Pharmaceuticals Global News & Press Release Distribution

Medical/Pharmaceuticals

All
APAC

Bridge Biotherapeutics Announces Data Presentation from First-in-Human Study of BBT-877 for Idiopathic Pulmonary Fibrosis

SEONGNAM, South Korea and DALLAS, May 20, 2019 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical-stage biotech company developing novel therapeutics for areas with high unmet medical needs, announced that the company presented interim data from a Phase I clinical study on BBT-877, a drug c...

2019-05-20 08:38 1814

ChemPartner and Berkeley Lights Take Next Step in B Cell Antibody Discovery Collaboration

SHANGHAI and SOUTH SAN FRANCISCO, Calif., May 16, 2019 /PRNewswire/ -- Shanghai ChemPartner a leading global Contract Research Organization (CRO), along withBerkeley Lights, Inc. (BLI) , the leader in digital cell biology, announced ...

2019-05-16 23:00 1777

Hebron Technology Co., Ltd. Reports Fiscal Year 2018 Financial Results

WENZHOU, China, May 15, 2019 /PRNewswire/ -- Hebron Technology Co., Ltd. (" Hebron" or the "Company") (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use in the pharmaceutical, biological, food and beverage, and other clean industries, today announced its f...

2019-05-16 05:00 11014

NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar, the Second Biosimilar from the 10-product Portfolio with Serum Institute

SYDNEY, May 15, 2019 /PRNewswire/ -- NeuClone Pharmaceuticals Ltd. (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced it will initiate the Phase I clinical trial of its Stelara® (ustekinumab) biosimilar in t...

2019-05-15 20:13 1900

NeuClone to Initiate Phase I Clinical Trial of Stelara (Ustekinumab) Biosimilar, the Second Biosimilar from the 10-product Portfolio with Serum Institute

China Pharma Holdings, Inc. Reports First Quarter 2019 Financial Results

HAIKOU, China, May 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter ...

2019-05-15 18:00 8359

Ortho Clinical Diagnostics to Host 4th Annual Hospital C-Suite Summit in Singapore

2-Day Summit Will Bring Together Top Hospital Executives and Focus on Patient Safety and Service Excellence RARITAN, New Jersey and SINGAPORE, May 14, 2019 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, in collaboration withSingapore Management University, w...

2019-05-14 07:00 2687

AirXpanders® Announces Special 510(k) Submission to the US FDA for a Smooth Shell Version of the AeroForm® Tissue Expander System

SAN JOSE, California, May 13, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the company has submitted a Special 510(k) pre-market notification to t...

2019-05-14 04:09 1111

China Biologic Reports Financial Results for the First Quarter of 2019

--1Q19 Total Sales Up 15.4% YoY in USD terms, or 22.3% YoY in RMB terms; Net Income Up 19.3% YoY to $37.7 Million; Non-GAAP Adjusted Net Income Up 14.3% YoY in RMB terms -- BEIJING, May 10, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"...

2019-05-11 04:30 9550

OliX Pharmaceuticals Expands Ocular Disease Pipeline; Adds OLX304A for the Treatment of Retinitis Pigmentosa

SUWON, South Korea, May 9, 2019 /PRNewswire/ -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics,announced today an expansion of its ocular disease pipeline. Specifically, the company announced that OLX304A has been added to develop an RNAi therapeutic with...

2019-05-10 09:24 1560

EnGeneIC Announces First Patients with Advanced-Stage Pancreatic Cancer Dosed in Phase 1/2a Clinical Study of Targeted Cytotoxic Immunotherapy

NEW YORK and SYDNEY, May 10, 2019 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV™ nanocell platform for targeted cyto-immunotherapy in cancer, today announced that the first four patients have been dosed in a Phase 1/2a study using the ...

2019-05-10 05:05 1146

AIMed and Best Case Scenario Announce New Partnership to Launch AIMed Australia

ORANGE, California, May 9, 2019 /PRNewswire/ -- AIMed, a leading provider of global clinician-led artificial intelligence events, education and editorial content in healthcare and medicine has announced today a new partnership with Best Case Scenario (BCS), a leading event management company base...

2019-05-09 07:00 1229

AirXpanders Engages Cowen to Explore Financial and Strategic Alternatives

SAN JOSE, California, May 9, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the Company has retained Cowen as an independent financial advisor to as...

2019-05-09 03:29 915

Kazia calls for greater awareness of the deadliest gynecological cancer in the US

SYDNEY, May 8, 2019 /PRNewswire/ -- This World Ovarian Cancer Day, Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) calls for greater awareness of what is the most lethal gynaecological cancer in the US. In 2019, around 22,530 women will receive a new d...

2019-05-08 20:00 6268

United Imaging Healthcare uPMR 790 HD TOF PET/MR Cleared by FDA

HOUSTON, May 8, 2019 /PRNewswire/ -- United Imaging Healthcare (UIH), an international leader in advanced medical imaging and radiotherapy equipment, announced the U.S. Food and Drug Administration (FDA) clearance of the uPMR 790 HD TOF PET/MR. uPMR 790 redefines clinical routine imaging for PET/...

2019-05-08 20:00 1132

GeneQuantum Healthcare completed nearly RMB 100 million in Pre-B financing

SUZHOU, China, May 7, 2019 /PRNewswire/ -- GeneQuantum Healthcare announced that it has closed nearlyRMB 100 million Pre-B round of financing. This financing was led by Huagai Capital, joined by Hofon Capital and Changjinboya. GeneQuantum Healthcare's A-round investor Oriza Seed and TF Capital co...

2019-05-08 08:00 1448

Canopy Growth Introduces Spectrum Therapeutics

SMITHS FALLS, Ontario, May 7, 2019 /PRNewswire/ -- Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all of the Company's ongoing medical and research operations including Sp...

2019-05-07 22:31 7082

CPHI to Hold First Quarter 2019 Earnings Conference Call On Wednesday, May 15, 2019 at 8:30 a.m. ET

HAIKOU, China, May 7, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its first quarter 2019 earnings conference c...

2019-05-07 20:00 7242

CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedures in the US West Coast

Four patients enrolled and treated by sports medicine surgeon Dr. Scott Hacker, MD KFAR SABA, Israel, May 7, 2019 /PRNewswire/ -- Scott A. Hacker, MD, a sports medicine orthopedic surgeon at Grossmont Hospital,San Diego, CA, enrolled and surgically treated the first four patients in the U.S....

2019-05-07 15:00 1072

CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedures in the US West Coast

1 ... 191 192 193 194195